Whole-genome sequencing (WGS) was employed to further discover the molecular basis of predisposition to CRC in patients fulfilling the Bethesda criteria, which demonstrated an intact protein expression of four common MMR genes: MLH1, MSH2, MSH6 and PMS2. Here, MSH6 is linked to colorectal carcinoma.